- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00213668
Effect of Glutamine on Gastric Emptying and Length of Parenteral Nutrition in Premature Neonates
June 17, 2013 updated by: University Hospital, Rouen
This study investigates the effects of enterally supplied glutamine on gastric emptying, intestinal transit, age of total enteral nutrition and age at the end of hospitalisation.
Forty neonates, aged at least 2 days and free of acute illness participate in a prospective, randomised, double-blind study.
All are fed with parenteral and enteral nutrition enriched with glutamine (0.7 g/kg/per day, group 1) or isonitrogenous control (group 2).
Gastric emptying is analysed by sequential measure of intragastric residue by diluted polyethylene glycol (PEG) 4000.
Intestinal transit is analysed by Rouge Carmin test.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rouen, France, 76031
- CHU-Rouen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 days to 1 week (Child)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Premature neonates aged 30-33 weeks of gestational age
- Aged at least 2 days and no more than 10 days
- Free of acute illness
- Written informed consent is obtained from the parent prior to enrolment.
Exclusion Criteria:
- Premature infants with respiratory (fraction of inspired oxygen [FiO2] > 30%), or cardiovascular, liver, intestinal or acute diseases
- Premature infants with congenital syndrome
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
gastric emptying
Time Frame: at day 0, day 1, day 7 and day 14 of enteral nutrition enriched by glutamine or isonitrogenous product
|
at day 0, day 1, day 7 and day 14 of enteral nutrition enriched by glutamine or isonitrogenous product
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
intestinal transit
Time Frame: at day 1 and day 14 of enteral nutrition enriched by glutamine or isonitrogenous product
|
at day 1 and day 14 of enteral nutrition enriched by glutamine or isonitrogenous product
|
date and duration of arrest of nutrition if necessary
|
|
age of total enteral nutrition
|
|
age at the end of hospitalization
|
|
variation of cholescystokinin and gastrin postprandial concentration
Time Frame: at day 0 and day 14
|
at day 0 and day 14
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Anne Mercier, MD, CHU Rouen
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2002
Study Registration Dates
First Submitted
September 13, 2005
First Submitted That Met QC Criteria
September 13, 2005
First Posted (Estimate)
September 21, 2005
Study Record Updates
Last Update Posted (Estimate)
June 18, 2013
Last Update Submitted That Met QC Criteria
June 17, 2013
Last Verified
June 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2000/111/HP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Enteral Feeding
-
University of MichiganChildren's Mercy Hospital Kansas CityTerminatedEnteral Nutrition | Enteral Feeding | Gastrostomy TubeUnited States
-
Société des Produits Nestlé (SPN)CompletedEnteral FeedingUnited States
-
Société des Produits Nestlé (SPN)Recruiting
-
Société des Produits Nestlé (SPN)Nutrasource Pharmaceutical and Nutraceutical Services, Inc.; Bruyere Research...Terminated
-
NestléCompleted
-
NestléCompleted
-
Sohag UniversityRecruitingEnteral Feeding IntoleranceEgypt
-
Brno University HospitalRecruitingEnteral Feeding IntoleranceCzechia
-
Mayo ClinicRecruiting
-
The University of Texas Health Science Center at...Avanos MedicalCompleted
Clinical Trials on glutamine (dipeptiven)
-
Scandinavian Critical Care Trials GroupTerminated
-
Air Force Specialized Hospital, Cairo, EgyptRecruiting
-
Institute of Child HealthCompletedSurgical Infants Requiring Total Parenteral NutritionUnited Kingdom
-
Emory UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Kocaeli UniversityCompletedColorectal Cancer | MalnutritionTurkey
-
Centre Hospitalier Universitaire de BesanconUnknownBiomarkers | Enteral Nutrition | Intensive Care Unit
-
Assiut UniversityCompleted
-
Yuejiang LiuCompletedCoronary Heart Disease | Rheumatic Heart DiseaseChina
-
Meshalkin Research Institute of Pathology of CirculationCompletedCoronary Artery DiseaseRussian Federation
-
University Medical Centre LjubljanaTerminated